![Tobias Sidelmann Christensen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Tobias Sidelmann Christensen
Amministratore Delegato presso Pharmacosmos A/S
Profilo
Tobias Sidelmann Christensen is currently the President & Chief Executive Officer at Pharmacosmos A.
He is also the Chief Executive Officer at SiBio ApS since 2019 and the Chairman at Pharmacosmos Holding A since 2020.
Additionally, he serves as a Director at Antoax A.
Mr. Christensen completed his undergraduate degree at the Massachusetts Institute of Technology.
Posizioni attive di Tobias Sidelmann Christensen
Società | Posizione | Inizio |
---|---|---|
Pharmacosmos Holding A/S
![]() Pharmacosmos Holding A/S Pharmaceuticals: MajorHealth Technology Pharmacosmos Holding A/S conducts business with the development of pharmaceutical, chemical, and technical products and processes. It also acquires, owns, and administers rights in connection therewith; and to own shares in companies engage in the development, production, and trade of pharmaceutical, chemical, and technical products. The company was founded on October 12, 1965 and is headquartered in Holbaek, Denmark. | Presidente | 09/09/2020 |
Antoax A/S
![]() Antoax A/S Financial ConglomeratesFinance Antoax A/S is an investment holding Danish company. The company is based in Holbæk, DK and has subsidiaries in the United States, Denmark, and the United Kingdom. The company was founded in 2004. The CEO is Robert Guglielmetti. | Direttore/Membro del Consiglio | - |
Pharmacosmos A/S
![]() Pharmacosmos A/S Pharmaceuticals: MajorHealth Technology Pharmacosmos A/S develops treatments of iron deficiency anemia in humans and animals. Its products include monofer, cosmofer, diafer and uniferon. The company was founded by Dr. Henry M. Christensen in 1965 and is headquartered in Holbæk, Denmark. | Amministratore Delegato | - |
Sibio ApS
![]() Sibio ApS Financial ConglomeratesFinance SiBio ApS is an investment holding Danish company. The private company is based in Holbæk, Denmark. The company was founded in 2019. Tobias Sidelmann Christensen has been the CEO of the company since 2019. | Amministratore Delegato | 22/10/2019 |
Formazione di Tobias Sidelmann Christensen
Massachusetts Institute of Technology | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 4 |
---|---|
Antoax A/S
![]() Antoax A/S Financial ConglomeratesFinance Antoax A/S is an investment holding Danish company. The company is based in Holbæk, DK and has subsidiaries in the United States, Denmark, and the United Kingdom. The company was founded in 2004. The CEO is Robert Guglielmetti. | Finance |
Pharmacosmos Holding A/S
![]() Pharmacosmos Holding A/S Pharmaceuticals: MajorHealth Technology Pharmacosmos Holding A/S conducts business with the development of pharmaceutical, chemical, and technical products and processes. It also acquires, owns, and administers rights in connection therewith; and to own shares in companies engage in the development, production, and trade of pharmaceutical, chemical, and technical products. The company was founded on October 12, 1965 and is headquartered in Holbaek, Denmark. | Health Technology |
Sibio ApS
![]() Sibio ApS Financial ConglomeratesFinance SiBio ApS is an investment holding Danish company. The private company is based in Holbæk, Denmark. The company was founded in 2019. Tobias Sidelmann Christensen has been the CEO of the company since 2019. | Finance |
Pharmacosmos A/S
![]() Pharmacosmos A/S Pharmaceuticals: MajorHealth Technology Pharmacosmos A/S develops treatments of iron deficiency anemia in humans and animals. Its products include monofer, cosmofer, diafer and uniferon. The company was founded by Dr. Henry M. Christensen in 1965 and is headquartered in Holbæk, Denmark. | Health Technology |
- Borsa valori
- Insiders
- Tobias Sidelmann Christensen